NeuroSense Therapeutics
NeuroSense Therapeutics

Wacker Biotech Unveils €100m RNA Manufacturing Site: Creating Jobs and Expanding Expertise!
BIOT
📢 German CDMO Wacker Biotech opens €100m RNA manufacturing site, creating 100 jobs and expanding expertise in RNA active ingredients. 💪🌍

Breakthrough Collaboration: Lonza AG and NeuroSense Join Forces to Revolutionize Neurodegeneration Research
BIOT
Lonza AG partners with NeuroSense Therapeutics to advance theranostics in neurodegeneration through exosome-based biomarkers. 🧠





